Sepsis Diagnostics Market Forecast, Trend Analysis & Competition Tracking - Global Market insights 2017 to 2026

  • Published : Jan-2018
  • Tables : 128
  • Figures : 102
  • Category : Healthcare
  • No. of Pages : 170
  • Report Code : FACT391MR
  • Format : ppt

Sepsis is emerging as one of the leading causes of mortality around the globe. However, early detection can improve the outcomes, hence the demand for sepsis diagnostics is also rising. Major companies in the market are also focusing on introducing technically advanced tools and techniques to provide sepsis diagnosis at an early stage. Companies are also entering into mergers and acquisitions to carry research and development activity and expand globally. New products are also being launched, while some products have already received the U.S. Food and Drugs Administration (FDA) clearance to be used for diagnosis purpose.

global sepsis diagnostics market

According to the new research by Fact.MR, the global market for sepsis diagnostics is likely to grow at a faster phase between 2017 and 2026. The global market for sepsis diagnostics is also projected to bring in US$ 707.3 million revenue by 2026 end.  

Market Taxonomy

Product Type

Method

Pathogen

Technology

Blood Culture Media

Conventional Diagnostics

Gram-negative Bacterial Sepsis

Microbiology

Instrument

Automated Diagnostics

Gram-positive Bacterial Sepsis

Molecular Diagnostics

Assays & Reagents

 

Fungal Sepsis

Immunoassays

   

Other Pathogens

Other Technology

(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)

Assays & Reagents to Emerge as the Top-Selling Product

Among various products in sepsis diagnostics market, assays & reagents are likely to emerge as the top-selling products. Assays & reagents are projected to surpass US$ 300 million revenue by end of the forecast period. Reagents and assays kits are showing lucrative growth due to the introduction of technically advanced tests by key players. Moreover, assays and reagents facilitate early diagnosis of sepsis.

Conventional Diagnostics to be the Most-Preferred diagnostic Method

Compared to the automated diagnostics, conventional diagnostics is likely to emerge as the most-preferred sepsis diagnosis method. Towards 2026 end, conventional diagnostics is projected to generate more than US$ 400 million revenue. Conventional methods for diagnosis of sepsis is still the most-preferred one due to the low cost and it also leads to the timely changes to appropriate therapy.

Gram-positive Bacterial Sepsis to Hold the Largest Share on Basis of Pathogens Causing Septicemia

Gram-positive bacterial sepsis segment is likely to account for the maximum share in terms of revenue in the global market for sepsis diagnostics. Gram-positive bacterial sepsis are projected to reach close to US$ 300 million revenue by 2026 end. Although bacteria causes sepsis on a large scale, the increase in sepsis is due to the gram-positive sepsis. Various studies carried on sepsis are showing that gram-positive bacteria accounts for maximum septic shock and severe sepsis cases. Moreover, the mortality rate due to gram-positive infection is high as compared to the gram-negative infection. Hence, therapeutic protocols are being undertaken to manage both gram-positive and gram-negative sepsis.

Microbiology Technology to Witness Attractive Growth between 2017 and 2026

Compared to the various technologies, microbiology is likely to show attractive growth between 2017 and 2026. Microbiology technology is projected to reach nearly US$ 300 million revenue by 2026 end. It helps in identifying microorganisms for sepsis diagnosis and quantitative detection through culture media tests. Meanwhile, molecular diagnostics is also gaining traction in the market. Factors contributing to the growth of molecular diagnostics are accurate results and low turnaround time.

Competition Tracking

The report also profiles companies that are expected to remain active in the expansion of global sepsis diagnostics market through 2026, which include Abionic SA, Biomérieux SA, Siemens Healthineers, Thermo Fisher Scientific Inc., Quidel Corporation, Becton, Dickinson and Company, Luminex Corporation, Abbott Laboratories, Inc., Qiagen NV, T2 Biosystems, Inc., Roche Holdings AG (Roche Diagnostics Limited), and Danaher Corporation (Beckman Coulter, Inc.).

NoteThe insights mentioned here are of the respective analysts, and do not reflect the position of Fact.M

1. Global Economic Outlook

2. Global Sepsis Diagnostics Market - Executive Summary

3. Global Sepsis Diagnostics Market Overview
3.1. Introduction
       3.1.1. Global Sepsis Diagnostics Market Taxonomy
       3.1.2. Global Sepsis Diagnostics Market Definition
3.2. Global Sepsis Diagnostics Market Size (US$ Mn) and Forecast, 2012-2026
       3.2.1. Global Sepsis Diagnostics Market Y-o-Y Growth
3.3. Global Sepsis Diagnostics Market Dynamics
3.4. Supply Chain
3.5. Cost Structure
3.6. New Technologies 
3.7. Sepsis types and mortality rates
3.8. Application of Sepsis Biomarkers
3.9. Early antimicrobial therapy in Septic Shock treatment
3.10. Commercially available systems and assays used for Sepsis diagnostics
3.11. Sepsis Epidemiology
3.12. Death rate of Sepsis as compared to other diseases
3.13. Surviving Sepsis Campaign
       3.13.1. Surviving Sepsis Campaign Guideline Process
3.14. PESTL Analysis
3.15. Product Lifecycle
3.16. Patent Analysis
3.17. Service Provider List
3.18. Key Participants Market Presence (Intensity Map) By Region

4. Global Sepsis Diagnostics Market Analysis and Forecast 2012-2026 
4.1. Global Sepsis Diagnostics Market Size and Forecast By Product Type, 2012-2026
       4.1.1. Blood Culture Media Market Size and Forecast, 2012-2026
                4.1.1.1. Revenue (US$ Mn) Comparison, By Region
                4.1.1.2. Market Share Comparison, By Region
                4.1.1.3. Y-o-Y growth Comparison, By Region
       4.1.2. Instrument Market Size and Forecast, 2012-2026
                4.1.2.1. Revenue (US$ Mn) Comparison, By Region
                4.1.2.2. Market Share Comparison, By Region
                4.1.2.3. Y-o-Y growth Comparison, By Region
       4.1.3. Assays & Reagents Market Size and Forecast, 2012-2026
                4.1.3.1. Revenue (US$ Mn) Comparison, By Region
                4.1.3.2. Market Share Comparison, By Region
                4.1.3.3. Y-o-Y growth Comparison, By Region
4.2. Global Sepsis Diagnostics Market Size and Forecast By Method, 2012-2026
       4.2.1. Conventional Diagnostics Market Size and Forecast, 2012-2026
                4.2.1.1. Revenue (US$ Mn) Comparison, By Region
                4.2.1.2. Market Share Comparison, By Region
                4.2.1.3. Y-o-Y growth Comparison, By Region
       4.2.2. Automated Diagnostics Market Size and Forecast, 2012-2026
                4.2.2.1. Revenue (US$ Mn) Comparison, By Region
                4.2.2.2. Market Share Comparison, By Region
                4.2.2.3. Y-o-Y growth Comparison, By Region
4.3. Global Sepsis Diagnostics Market Size and Forecast By Pathogen, 2012-2026
       4.3.1. Gram-negative Bacterial Sepsis Market Size and Forecast, 2012-2026
                4.3.1.1. Revenue (US$ Mn) Comparison, By Region
                4.3.1.2. Market Share Comparison, By Region
                4.3.1.3. Y-o-Y growth Comparison, By Region
       4.3.2. Gram-positive Bacterial Sepsis Market Size and Forecast, 2012-2026
                4.3.2.1. Revenue (US$ Mn) Comparison, By Region
                4.3.2.2. Market Share Comparison, By Region
                4.3.2.3. Y-o-Y growth Comparison, By Region
       4.3.3. Fungal Sepsis Market Size and Forecast, 2012-2026
                4.3.3.1. Revenue (US$ Mn) Comparison, By Region
                4.3.3.2. Market Share Comparison, By Region
                4.3.3.3. Y-o-Y growth Comparison, By Region
       4.3.4. Other Pathogens Market Size and Forecast, 2012-2026
                4.3.4.1. Revenue (US$ Mn) Comparison, By Region
                4.3.4.2. Market Share Comparison, By Region
                4.3.4.3. Y-o-Y growth Comparison, By Region
4.4. Global Sepsis Diagnostics Market Size and Forecast By Technology, 2012-2026
       4.4.1. Microbiology Market Size and Forecast, 2012-2026
                4.4.1.1. Revenue (US$ Mn) Comparison, By Region
                4.4.1.2. Market Share Comparison, By Region
                4.4.1.3. Y-o-Y growth Comparison, By Region
       4.4.2. Molecular Diagnostics Market Size and Forecast, 2012-2026
                4.4.2.1. Revenue (US$ Mn) Comparison, By Region
                4.4.2.2. Market Share Comparison, By Region
                4.4.2.3. Y-o-Y growth Comparison, By Region
       4.4.4. Flow Cytometry Market Size and Forecast, 2012-2026
                4.4.4.1. Revenue (US$ Mn) Comparison, By Region
                4.4.4.2. Market Share Comparison, By Region
                4.4.4.3. Y-o-Y growth Comparison, By Region
       4.4.4. Flow Cytometry Market Size and Forecast, 2012-2026
                4.4.4.1. Revenue (US$ Mn) Comparison, By Region
                4.4.4.2. Market Share Comparison, By Region
                4.4.4.3. Y-o-Y growth Comparison, By Region

5. North America Sepsis Diagnostics Market Size and Forecast, 2012-2026
5.1. North America Outlook 
5.2. North America Parent Market Outlook 
5.3. North America Target Market Outlook 
5.4. Revenue (US$ Mn) Comparison, By Country 
       5.4.1. US Market Size and Forecast (US$ Mn), 2012-2026
       5.4.2. Canada Market Size and Forecast (US$ Mn), 2012-2026
5.5. Revenue (US$ Mn) Comparison, By Product Type 
5.6. Revenue (US$ Mn) Comparison, By Method 
5.7. Revenue (US$ Mn) Comparison, By Pathogen 
5.8. Revenue (US$ Mn) Comparison, By Technology 

6. Latin America Sepsis Diagnostics Market Size and Forecast, 2012-2026
6.1. Latin America Outlook 
6.2. Latin America Parent Market Outlook 
6.3. Latin America Target Market Outlook 
6.4. Revenue (US$ Mn) Comparison, By Country 
       6.4.1. Brazil Market Size and Forecast (US$ Mn), 2012-2026
       6.4.2. Mexico Market Size and Forecast (US$ Mn), 2012-2026
       6.4.3. Rest of Latin America Market Size and Forecast (US$ Mn), 2012-2026
6.5. Revenue (US$ Mn) Comparison, By Product Type 
6.6. Revenue (US$ Mn) Comparison, By Method 
6.7. Revenue (US$ Mn) Comparison, By Pathogen 
6.8. Revenue (US$ Mn) Comparison, By Technology 

7. Europe Sepsis Diagnostics Market Size and Forecast, 2012-2026
7.1. Europe Outlook 
7.2. Europe Parent Market Outlook 
7.3. Europe Target Market Outlook 
7.4. Revenue (US$ Mn) Comparison, By Country 
       7.4.1. Germany Market Size and Forecast (US$ Mn), 2012-2026
       7.4.2. UK Market Size and Forecast (US$ Mn), 2012-2026
       7.4.3. France Market Size and Forecast (US$ Mn), 2012-2026
       7.4.4. Spain Market Size and Forecast (US$ Mn), 2012-2026
       7.4.5. Italy Market Size and Forecast (US$ Mn), 2012-2026
       7.4.6. Rest of Europe Market Size and Forecast (US$ Mn), 2012-2026
7.5. Revenue (US$ Mn) Comparison, By Product Type 
7.6. Revenue (US$ Mn) Comparison, By Method 
7.7. Revenue (US$ Mn) Comparison, By Pathogen 
7.8. Revenue (US$ Mn) Comparison, By Technology 

8. Japan Sepsis Diagnostics Market Size and Forecast, 2012-2026
8.1. Japan Outlook 
8.2. Japan Parent Market Outlook 
8.3. Japan Target Market Outlook 
8.4. Revenue (US$ Mn) Comparison, By Country 
       8.4.1. Japan Market Size and Forecast (US$ Mn), 2012-2026
8.5. Revenue (US$ Mn) Comparison, By Product Type 
8.6. Revenue (US$ Mn) Comparison, By Method 
8.7. Revenue (US$ Mn) Comparison, By Pathogen 
8.8. Revenue (US$ Mn) Comparison, By Technology 

9. APEJ Sepsis Diagnostics Market Size and Forecast, 2012-2026
9.1. APEJ Outlook 
9.2. APEJ Parent Market Outlook 
9.3. APEJ Target Market Outlook 
9.4. Revenue (US$ Mn) Comparison, By Country 
       9.4.1. China Market Size and Forecast (US$ Mn), 2012-2026
       9.4.2. India Market Size and Forecast (US$ Mn), 2012-2026
       9.4.3. Thailand Market Size and Forecast (US$ Mn), 2012-2026
       9.4.4. Singapore Market Size and Forecast (US$ Mn), 2012-2026
       9.4.5. Australia Market Size and Forecast (US$ Mn), 2012-2026
       9.4.6. Rest of APEJ Market Size and Forecast (US$ Mn), 2012-2026
9.5. Revenue (US$ Mn) Comparison, By Product Type 
9.6. Revenue (US$ Mn) Comparison, By Method 
9.7. Revenue (US$ Mn) Comparison, By Pathogen 
9.8. Revenue (US$ Mn) Comparison, By Technology 

10. MEA Sepsis Diagnostics Market Size and Forecast, 2012-2026
10.1. MEA Outlook 
10.2. MEA Parent Market Outlook 
10.3. MEA Target Market Outlook 
10.4. Revenue (US$ Mn) Comparison, By Country 
       10.4.1. GCC Countries Market Size and Forecast (US$ Mn), 2012-2026
       10.4.2. South Africa Market Size and Forecast (US$ Mn), 2012-2026
       10.4.3. Israel Market Size and Forecast (US$ Mn), 2012-2026
       10.4.4. Rest of MEA Market Size and Forecast (US$ Mn), 2012-2026
10.5. Revenue (US$ Mn) Comparison, By Product Type 
10.6. Revenue (US$ Mn) Comparison, By Method 
10.7. Revenue (US$ Mn) Comparison, By Pathogen 
10.8. Revenue (US$ Mn) Comparison, By Technology 

11. Global Sepsis Diagnostics Market Company Share, Competition Landscape and Company Profiles
11.1. Company Share Analysis
11.2. Competition Landscape
11.3. Company Profiles
       11.3.1. Biomérieux SA 
       11.3.2. Becton, Dickinson and Company 
       11.3.3. Thermo Fisher Scientific Inc. 
       11.3.4. Abbott Laboratories, Inc. 
       11.3.5. Roche Holdings AG (Roche Diagnostics Limited)
       11.3.6. T2 Biosystems, Inc. 
       11.3.7. Danaher Corporation (Beckman Coulter, Inc.)
       11.3.8. Luminex Corporation 
       11.3.9. Qiagen NV
       11.3.10. Siemens Healthineers
       11.3.11. Quidel Corporation 
       11.3.12. Abionic SA
       11.3.13. OpGen, Inc.
       11.3.14. Curetis N.V.
       11.3.15. CytoSorbents Corporation
       11.3.16. Fujirebio Europe NV
       11.3.17. Hansa Medical AB
       11.3.18. Hain Lifescience GmbH
       11.3.19. Immunexpress Pty Ltd
       11.3.20.Inflammatix, Inc.
       11.3.21.Miacom diagnostics GmbH
       11.3.22.Nanomix, Inc.
       11.3.23.Radiometer Medical Aps
       11.3.24.Response Biomedical Corp.
       11.3.25.Sekisui Diagnostics LLC

12. Research Methodology

13. Secondary and Primary Sources

14. Assumptions and Acronyms

15. Disclaimer

TABLE 1 Global Sepsis Diagnostics Market Value (US$ Mn), 2012-2017
TABLE 2 Global Sepsis Diagnostics Market Value (US$ Mn), 2018-2026
TABLE 3 Global Sepsis Diagnostics Market Value (US$ Mn) and Y-o-Y, 2017-2026
TABLE 4 Global Blood Culture Media Segment Value (US$ Mn), By Region 2012-2017
TABLE 5 Global Blood Culture Media Segment Value (US$ Mn), By Region 2018-2026
TABLE 6 Global Blood Culture Media Segment Market Share, By Region 2012-2017
TABLE 7 Global Blood Culture Media Segment Market Share, By Region 2018-2026
TABLE 8 Global Blood Culture Media Segment Y-o-Y, By Region 2017-2026
TABLE 9 Global Instrument Segment Value (US$ Mn), By Region 2012-2017
TABLE 10 Global Instrument Segment Value (US$ Mn), By Region 2018-2026
TABLE 11 Global Instrument Segment Market Share, By Region 2012-2017
TABLE 12 Global Instrument Segment Market Share, By Region 2018-2026
TABLE 13 Global Instrument Segment Y-o-Y, By Region 2017-2026
TABLE 14 Global Assays & Reagents Segment Value (US$ Mn), By Region 2012-2017
TABLE 15 Global Assays & Reagents Segment Value (US$ Mn), By Region 2018-2026
TABLE 16 Global Assays & Reagents Segment Market Share, By Region 2012-2017
TABLE 17 Global Assays & Reagents Segment Market Share, By Region 2018-2026
TABLE 18 Global Assays & Reagents Segment Y-o-Y, By Region 2017-2026
TABLE 19 Global Conventional Diagnostics Segment Value (US$ Mn), By Region 2012-2017
TABLE 20 Global Conventional Diagnostics Segment Value (US$ Mn), By Region 2018-2026
TABLE 21 Global Conventional Diagnostics Segment Market Share, By Region 2012-2017
TABLE 22 Global Conventional Diagnostics Segment Market Share, By Region 2018-2026
TABLE 23 Global Conventional Diagnostics Segment Y-o-Y, By Region 2017-2026
TABLE 24 Global Automated Diagnostics Segment Value (US$ Mn), By Region 2012-2017
TABLE 25 Global Automated Diagnostics Segment Value (US$ Mn), By Region 2018-2026
TABLE 26 Global Automated Diagnostics Segment Market Share, By Region 2012-2017
TABLE 27 Global Automated Diagnostics Segment Market Share, By Region 2018-2026
TABLE 28 Global Automated Diagnostics Segment Y-o-Y, By Region 2017-2026
TABLE 29 Global Gram-negative Bacterial Sepsis Segment Value (US$ Mn), By Region 2012-2017
TABLE 30 Global Gram-negative Bacterial Sepsis Segment Value (US$ Mn), By Region 2018-2026
TABLE 31 Global Gram-negative Bacterial Sepsis Segment Market Share, By Region 2012-2017
TABLE 32 Global Gram-negative Bacterial Sepsis Segment Market Share, By Region 2018-2026
TABLE 33 Global Gram-negative Bacterial Sepsis Segment Y-o-Y, By Region 2017-2026
TABLE 34 Global Gram-positive Bacterial Sepsis Segment Value (US$ Mn), By Region 2012-2017
TABLE 35 Global Gram-positive Bacterial Sepsis Segment Value (US$ Mn), By Region 2018-2026
TABLE 36 Global Gram-positive Bacterial Sepsis Segment Market Share, By Region 2012-2017
TABLE 37 Global Gram-positive Bacterial Sepsis Segment Market Share, By Region 2018-2026
TABLE 38 Global Gram-positive Bacterial Sepsis Segment Y-o-Y, By Region 2017-2026
TABLE 39 Global Fungal Sepsis Segment Value (US$ Mn), By Region 2012-2017
TABLE 40 Global Fungal Sepsis Segment Value (US$ Mn), By Region 2018-2026
TABLE 41 Global Fungal Sepsis Segment Market Share, By Region 2012-2017
TABLE 42 Global Fungal Sepsis Segment Market Share, By Region 2018-2026
TABLE 43 Global Fungal Sepsis Segment Y-o-Y, By Region 2017-2026
TABLE 44 Global Other Pathogens Segment Value (US$ Mn), By Region 2012-2017
TABLE 45 Global Other Pathogens Segment Value (US$ Mn), By Region 2018-2026
TABLE 46 Global Other Pathogens Segment Market Share, By Region 2012-2017
TABLE 47 Global Other Pathogens Segment Market Share, By Region 2018-2026
TABLE 48 Global Other Pathogens Segment Y-o-Y, By Region 2017-2026
TABLE 49 Global Microbiology Segment Value (US$ Mn), By Region 2012-2017
TABLE 50 Global Microbiology Segment Value (US$ Mn), By Region 2018-2026
TABLE 51 Global Microbiology Segment Market Share, By Region 2012-2017
TABLE 52 Global Microbiology Segment Market Share, By Region 2018-2026
TABLE 53 Global Microbiology Segment Y-o-Y, By Region 2017-2026
TABLE 54 Global Molecular Diagnostics Segment Value (US$ Mn), By Region 2012-2017
TABLE 55 Global Molecular Diagnostics Segment Value (US$ Mn), By Region 2018-2026
TABLE 56 Global Molecular Diagnostics Segment Market Share, By Region 2012-2017
TABLE 57 Global Molecular Diagnostics Segment Market Share, By Region 2018-2026
TABLE 58 Global Molecular Diagnostics Segment Y-o-Y, By Region 2017-2026
TABLE 59 Global Immunoassays Segment Value (US$ Mn), By Region 2012-2017
TABLE 60 Global Immunoassays Segment Value (US$ Mn), By Region 2018-2026
TABLE 61 Global Immunoassays Segment Market Share, By Region 2012-2017
TABLE 62 Global Immunoassays Segment Market Share, By Region 2018-2026
TABLE 63 Global Immunoassays Segment Y-o-Y, By Region 2017-2026
TABLE 64 Global Other Technology Segment Value (US$ Mn), By Region 2012-2017
TABLE 65 Global Other Technology Segment Value (US$ Mn), By Region 2018-2026
TABLE 66 Global Other Technology Segment Market Share, By Region 2012-2017
TABLE 67 Global Other Technology Segment Market Share, By Region 2018-2026
TABLE 68 Global Other Technology Segment Y-o-Y, By Region 2017-2026
TABLE 69 North America Sepsis Diagnostics Market Value (US$ Mn), By Country 2012-2017
TABLE 70 North America Sepsis Diagnostics Market Value (US$ Mn), By Country 2018-2026
TABLE 71 North America Sepsis Diagnostics Market Value (US$ Mn), By Product Type 2012-2017
TABLE 72 North America Sepsis Diagnostics Market Value (US$ Mn), By Product Type 2018-2026
TABLE 73 North America Sepsis Diagnostics Market Value (US$ Mn), By Method 2012-2017
TABLE 74 North America Sepsis Diagnostics Market Value (US$ Mn), By Method 2018-2026
TABLE 75 North America Sepsis Diagnostics Market Value (US$ Mn), By Pathogen 2012-2017
TABLE 76 North America Sepsis Diagnostics Market Value (US$ Mn), By Pathogen 2018-2026
TABLE 77 North America Sepsis Diagnostics Market Value (US$ Mn), By Technology 2012-2017
TABLE 78 North America Sepsis Diagnostics Market Value (US$ Mn), By Technology 2018-2026
TABLE 79 Latin America Sepsis Diagnostics Market Value (US$ Mn), By Country 2012-2017
TABLE 80 Latin America Sepsis Diagnostics Market Value (US$ Mn), By Country 2018-2026
TABLE 81 Latin America Sepsis Diagnostics Market Value (US$ Mn), By Product Type 2012-2017
TABLE 82 Latin America Sepsis Diagnostics Market Value (US$ Mn), By Product Type 2018-2026
TABLE 83 Latin America Sepsis Diagnostics Market Value (US$ Mn), By Method 2012-2017
TABLE 84 Latin America Sepsis Diagnostics Market Value (US$ Mn), By Method 2018-2026
TABLE 85 Latin America Sepsis Diagnostics Market Value (US$ Mn), By Pathogen 2012-2017
TABLE 86 Latin America Sepsis Diagnostics Market Value (US$ Mn), By Pathogen 2018-2026
TABLE 87 Latin America Sepsis Diagnostics Market Value (US$ Mn), By Technology 2012-2017
TABLE 88 Latin America Sepsis Diagnostics Market Value (US$ Mn), By Technology 2018-2026
TABLE 89 Europe Sepsis Diagnostics Market Value (US$ Mn), By Country 2012-2017
TABLE 90 Europe Sepsis Diagnostics Market Value (US$ Mn), By Country 2018-2026
TABLE 91 Europe Sepsis Diagnostics Market Value (US$ Mn), By Product Type 2012-2017
TABLE 92 Europe Sepsis Diagnostics Market Value (US$ Mn), By Product Type 2018-2026
TABLE 93 Europe Sepsis Diagnostics Market Value (US$ Mn), By Method 2012-2017
TABLE 94 Europe Sepsis Diagnostics Market Value (US$ Mn), By Method 2018-2026
TABLE 95 Europe Sepsis Diagnostics Market Value (US$ Mn), By Pathogen 2012-2017
TABLE 96 Europe Sepsis Diagnostics Market Value (US$ Mn), By Pathogen 2018-2026
TABLE 97 Europe Sepsis Diagnostics Market Value (US$ Mn), By Technology 2012-2017
TABLE 98 Europe Sepsis Diagnostics Market Value (US$ Mn), By Technology 2018-2026
TABLE 99 Japan Sepsis Diagnostics Market Value (US$ Mn), By Country 2012-2017
TABLE 100 Japan Sepsis Diagnostics Market Value (US$ Mn), By Country 2018-2026
TABLE 101 Japan Sepsis Diagnostics Market Value (US$ Mn), By Product Type 2012-2017
TABLE 102 Japan Sepsis Diagnostics Market Value (US$ Mn), By Product Type 2018-2026
TABLE 103 Japan Sepsis Diagnostics Market Value (US$ Mn), By Method 2012-2017
TABLE 104 Japan Sepsis Diagnostics Market Value (US$ Mn), By Method 2018-2026
TABLE 105 Japan Sepsis Diagnostics Market Value (US$ Mn), By Pathogen 2012-2017
TABLE 106 Japan Sepsis Diagnostics Market Value (US$ Mn), By Pathogen 2018-2026
TABLE 107 Japan Sepsis Diagnostics Market Value (US$ Mn), By Technology 2012-2017
TABLE 108 Japan Sepsis Diagnostics Market Value (US$ Mn), By Technology 2018-2026
TABLE 109 APEJ Sepsis Diagnostics Market Value (US$ Mn), By Country 2012-2017
TABLE 110 APEJ Sepsis Diagnostics Market Value (US$ Mn), By Country 2018-2026
TABLE 111 APEJ Sepsis Diagnostics Market Value (US$ Mn), By Product Type 2012-2017
TABLE 112 APEJ Sepsis Diagnostics Market Value (US$ Mn), By Product Type 2018-2026
TABLE 113 APEJ Sepsis Diagnostics Market Value (US$ Mn), By Method 2012-2017
TABLE 114 APEJ Sepsis Diagnostics Market Value (US$ Mn), By Method 2018-2026
TABLE 115 APEJ Sepsis Diagnostics Market Value (US$ Mn), By Pathogen 2012-2017
TABLE 116 APEJ Sepsis Diagnostics Market Value (US$ Mn), By Pathogen 2018-2026
TABLE 117 APEJ Sepsis Diagnostics Market Value (US$ Mn), By Technology 2012-2017
TABLE 118 APEJ Sepsis Diagnostics Market Value (US$ Mn), By Technology 2018-2026
TABLE 119 MEA Sepsis Diagnostics Market Value (US$ Mn), By Country 2012-2017
TABLE 120 MEA Sepsis Diagnostics Market Value (US$ Mn), By Country 2018-2026
TABLE 121 MEA Sepsis Diagnostics Market Value (US$ Mn), By Product Type 2012-2017
TABLE 122 MEA Sepsis Diagnostics Market Value (US$ Mn), By Product Type 2018-2026
TABLE 123 MEA Sepsis Diagnostics Market Value (US$ Mn), By Method 2012-2017
TABLE 124 MEA Sepsis Diagnostics Market Value (US$ Mn), By Method 2018-2026
TABLE 125 MEA Sepsis Diagnostics Market Value (US$ Mn), By Pathogen 2012-2017
TABLE 126 MEA Sepsis Diagnostics Market Value (US$ Mn), By Pathogen 2018-2026
TABLE 127 MEA Sepsis Diagnostics Market Value (US$ Mn), By Technology 2012-2017
TABLE 128 MEA Sepsis Diagnostics Market Value (US$ Mn), By Technology 2018-2026

FIG. 1 Global Sepsis Diagnostics Market Value (US$ Mn), 2012-2017
FIG. 2 Global Sepsis Diagnostics Market Value (US$ Mn) Forecast, 2018-2026
FIG. 3 Global Sepsis Diagnostics Market Value (US$ Mn) and Y-o-Y, 2017-2026
FIG. 4 Global Blood Culture Media Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 5 Global Blood Culture Media Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 6 Global Blood Culture Media Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 7 Global Instrument Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 8 Global Instrument Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 9 Global Instrument Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 10 Global Assays & Reagents Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 11 Global Assays & Reagents Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 12 Global Assays & Reagents Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 13 Global Conventional Diagnostics Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 14 Global Conventional Diagnostics Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 15 Global Conventional Diagnostics Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 16 Global Automated Diagnostics Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 17 Global Automated Diagnostics Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 18 Global Automated Diagnostics Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 19 Global Gram-negative Bacterial Sepsis Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 20 Global Gram-negative Bacterial Sepsis Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 21 Global Gram-negative Bacterial Sepsis Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 22 Global Gram-positive Bacterial Sepsis Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 23 Global Gram-positive Bacterial Sepsis Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 24 Global Gram-positive Bacterial Sepsis Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 25 Global Fungal Sepsis Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 26 Global Fungal Sepsis Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 27 Global Fungal Sepsis Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 28 Global Other Pathogens Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 29 Global Other Pathogens Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 30 Global Other Pathogens Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 31 Global Microbiology Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 32 Global Microbiology Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 33 Global Microbiology Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 34 Global Molecular Diagnostics Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 35 Global Molecular Diagnostics Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 36 Global Molecular Diagnostics Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 37 Global Immunoassays Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 38 Global Immunoassays Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 39 Global Immunoassays Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 40 Global Other Technology Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 41 Global Other Technology Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 42 Global Other Technology Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 43 North America Sepsis Diagnostics Market Value (US$ Mn), By Country 2012-2017
FIG. 44 North America Sepsis Diagnostics Market Value (US$ Mn), By Country 2018-2026
FIG. 45 North America Sepsis Diagnostics Market Value (US$ Mn), By Product Type 2012-2017
FIG. 46 North America Sepsis Diagnostics Market Value (US$ Mn), By Product Type 2018-2026
FIG. 47 North America Sepsis Diagnostics Market Value (US$ Mn), By Method 2012-2017
FIG. 48 North America Sepsis Diagnostics Market Value (US$ Mn), By Method 2018-2026
FIG. 49 North America Sepsis Diagnostics Market Value (US$ Mn), By Pathogen 2012-2017
FIG. 50 North America Sepsis Diagnostics Market Value (US$ Mn), By Pathogen 2018-2026
FIG. 51 North America Sepsis Diagnostics Market Value (US$ Mn), By Technology 2012-2017
FIG. 52 North America Sepsis Diagnostics Market Value (US$ Mn), By Technology 2018-2026
FIG. 53 Latin America Sepsis Diagnostics Market Value (US$ Mn), By Country 2012-2017
FIG. 54 Latin America Sepsis Diagnostics Market Value (US$ Mn), By Country 2018-2026
FIG. 55 Latin America Sepsis Diagnostics Market Value (US$ Mn), By Product Type 2012-2017
FIG. 56 Latin America Sepsis Diagnostics Market Value (US$ Mn), By Product Type 2018-2026
FIG. 57 Latin America Sepsis Diagnostics Market Value (US$ Mn), By Method 2012-2017
FIG. 58 Latin America Sepsis Diagnostics Market Value (US$ Mn), By Method 2018-2026
FIG. 59 Latin America Sepsis Diagnostics Market Value (US$ Mn), By Pathogen 2012-2017
FIG. 60 Latin America Sepsis Diagnostics Market Value (US$ Mn), By Pathogen 2018-2026
FIG. 61 Latin America Sepsis Diagnostics Market Value (US$ Mn), By Technology 2012-2017
FIG. 62 Latin America Sepsis Diagnostics Market Value (US$ Mn), By Technology 2018-2026
FIG. 63 Europe Sepsis Diagnostics Market Value (US$ Mn), By Country 2012-2017
FIG. 64 Europe Sepsis Diagnostics Market Value (US$ Mn), By Country 2018-2026
FIG. 65 Europe Sepsis Diagnostics Market Value (US$ Mn), By Product Type 2012-2017
FIG. 66 Europe Sepsis Diagnostics Market Value (US$ Mn), By Product Type 2018-2026
FIG. 67 Europe Sepsis Diagnostics Market Value (US$ Mn), By Method 2012-2017
FIG. 68 Europe Sepsis Diagnostics Market Value (US$ Mn), By Method 2018-2026
FIG. 69 Europe Sepsis Diagnostics Market Value (US$ Mn), By Pathogen 2012-2017
FIG. 70 Europe Sepsis Diagnostics Market Value (US$ Mn), By Pathogen 2018-2026
FIG. 71 Europe Sepsis Diagnostics Market Value (US$ Mn), By Technology 2012-2017
FIG. 72 Europe Sepsis Diagnostics Market Value (US$ Mn), By Technology 2018-2026
FIG. 73 Japan Sepsis Diagnostics Market Value (US$ Mn), By Country 2012-2017
FIG. 74 Japan Sepsis Diagnostics Market Value (US$ Mn), By Country 2018-2026
FIG. 75 Japan Sepsis Diagnostics Market Value (US$ Mn), By Product Type 2012-2017
FIG. 76 Japan Sepsis Diagnostics Market Value (US$ Mn), By Product Type 2018-2026
FIG. 77 Japan Sepsis Diagnostics Market Value (US$ Mn), By Pathogen 2012-2017
FIG. 78 Japan Sepsis Diagnostics Market Value (US$ Mn), By Method 2018-2026
FIG. 79 Japan Sepsis Diagnostics Market Value (US$ Mn), By Pathogen 2012-2017
FIG. 80 Japan Sepsis Diagnostics Market Value (US$ Mn), By Pathogen 2018-2026
FIG. 81 Japan Sepsis Diagnostics Market Value (US$ Mn), By Technology 2012-2017
FIG. 82 Japan Sepsis Diagnostics Market Value (US$ Mn), By Technology 2018-2026
FIG. 83 APEJ Sepsis Diagnostics Market Value (US$ Mn), By Country 2012-2017
FIG. 84 APEJ Sepsis Diagnostics Market Value (US$ Mn), By Country 2018-2026
FIG. 85 APEJ Sepsis Diagnostics Market Value (US$ Mn), By Product Type 2012-2017
FIG. 86 APEJ Sepsis Diagnostics Market Value (US$ Mn), By Product Type 2018-2026
FIG. 87 APEJ Sepsis Diagnostics Market Value (US$ Mn), By Method 2012-2017
FIG. 88 APEJ Sepsis Diagnostics Market Value (US$ Mn), By Method 2018-2026
FIG. 89 APEJ Sepsis Diagnostics Market Value (US$ Mn), By Pathogen 2012-2017
FIG. 90 APEJ Sepsis Diagnostics Market Value (US$ Mn), By Pathogen 2018-2026
FIG. 91 APEJ Sepsis Diagnostics Market Value (US$ Mn), By Technology 2012-2017
FIG. 92 APEJ Sepsis Diagnostics Market Value (US$ Mn), By Technology 2018-2026
FIG. 93 MEA Sepsis Diagnostics Market Value (US$ Mn), By Country 2012-2017
FIG. 94 MEA Sepsis Diagnostics Market Value (US$ Mn), By Country 2018-2026
FIG. 95 MEA Sepsis Diagnostics Market Value (US$ Mn), By Product Type 2012-2017
FIG. 96 MEA Sepsis Diagnostics Market Value (US$ Mn), By Product Type 2018-2026
FIG. 97 MEA Sepsis Diagnostics Market Value (US$ Mn), By Method 2012-2017
FIG. 98 MEA Sepsis Diagnostics Market Value (US$ Mn), By Method 2018-2026
FIG. 99 MEA Sepsis Diagnostics Market Value (US$ Mn), By Pathogen 2012-2017
FIG. 100 MEA Sepsis Diagnostics Market Value (US$ Mn), By Pathogen 2018-2026
FIG. 101 MEA Sepsis Diagnostics Market Value (US$ Mn), By Technology 2012-2017
FIG. 102 MEA Sepsis Diagnostics Market Value (US$ Mn), By Technology 2018-2026

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Benefits of Becoming a Fact.MR Client

  • Access to our global market coverage
  • Periodic updates on your sector
  • Exclusive discounts and offers
  • Greater flexibility for customization
  • Quick-research assistance for ad-hoc needs
  • Access to credible insights Fact.MR analyst interactions
  • Access to Fact.MR tools and research to fuel strategy development